Successful newborn screening for SCID in the Navajo Nation

Clinical Immunology

Volumn 158, Issue 1, 2015, Pages 29-34

  Kwan, Antonia ^a   Hu, Diana ^b   Song, Miran ^b   Gomes, Heidi ^c   Brown, Denise R ^b   Bourque, Trudy ^c   Gonzalez Espinosa, Diana ^a   Lin, Zhili ^d   Cowan, Morton J ^a   Puck, Jennifer M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Tuba City Regional Health Care Corporation   (United States)

^c Chinle Comprehensive Health Care Facility   (United States)

^d PERKINELMER INC   (United States)

Author keywords

Artemis; Navajo; Newborn screening; Primary immunodeficiency; SCID; TREC

Indexed keywords

BASILIXIMAB; BETA ACTIN; CALCIUM; DNA; IMMUNOGLOBULIN; INACTIVATED VACCINE; METHYLPREDNISOLONE; PREDNISOLONE; RAPAMYCIN; ROTAVIRUS VACCINE; T LYMPHOCYTE RECEPTOR; THYMOCYTE ANTIBODY; DCLRE1C PROTEIN, HUMAN; NUCLEAR PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CD3+ T LYMPHOCYTE; CHILD CARE; CONGENITAL MALFORMATION; DNA ISOLATION; DRIED BLOOD SPOT TESTING; FAMILY HISTORY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GESTATIONAL AGE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC ANEMIA; HUMAN; HYPOPARATHYROIDISM; INFANT; LOOSE FECES; LUNG INFILTRATE; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NEWBORN SCREENING; NEWBORN TETANUS; PHYSICAL EXAMINATION; PILOT STUDY; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SCOLIOSIS; SEVERE COMBINED IMMUNODEFICIENCY; T CELL DEPLETION; THORAX RADIOGRAPHY; VACCINATION; VEIN OCCLUSION; VITAMIN SUPPLEMENTATION; AMERICAN INDIAN; FEASIBILITY STUDY; GENETICS; LYMPHOPENIA; NEWBORN;

FEASIBILITY STUDIES; HUMANS; INDIANS, NORTH AMERICAN; INFANT, NEWBORN; LYMPHOPENIA; NEONATAL SCREENING; NUCLEAR PROTEINS; PILOT PROJECTS; POLYMERASE CHAIN REACTION; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 84925424134     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2015.02.015     Document Type: Article

References (23)

1. Al-Herz W., et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front. Immunol. 2011, 2:54.
2. Verbsky J., Thakar M., Routes J. The Wisconsin approach to newborn screening for severe combined immunodeficiency. J. Allergy Clin. Immunol. 2012, 129(3):622-627.
3. Kwan A., et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2years. J. Allergy Clin. Immunol. 2013, 132(1):140-150 e7.
4. Kwan A., et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 2014, 312(7):729-738.
5. Dvorak C.C., et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. J. Clin. Immunol. 2013, 33(7):1156-1164.
6. Pai S.Y., et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. New Engl. J. Med. 2014, 371(5):434-446.
7. Dvorak C.C., Cowan M.J. Radiosensitive severe combined immunodeficiency disease. Immunol. Allergy Clin. N. Am. 2010, 30(1):125-142.
8. de Villartay J.P., et al. Human and animal models of V(D)J recombination deficiency. Curr. Opin. Immunol. 2003, 15(5):592-598.
9. Murphy S., et al. Gene enrichment in an American Indian population: an excess of severe combined immunodeficiency disease. Lancet 1980, 2(8193):502-505.
10. Li L., et al. A founder mutation in Artemis, an SNM1-like protein, causes SCID in Athabascan-speaking Native Americans. J. Immunol. 2002, 168(12):6323-6329.
11. Cheek L.W. The Navajo long walk. Look West Series 2004, 64. Rio Nuevo Publishers, Tucson.
12. Jones J.F., et al. Severe combined immunodeficiency among the Navajo. I. Characterization of phenotypes, epidemiology, and population genetics. Hum. Biol. 1991, 63(5):669-682.
13. Li L., et al. Prenatal diagnosis and carrier detection for Athabascan severe combined immunodeficiency disease. Prenat. Diagn. 2002, 22(9):763-768.
14. Douek D.C., et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000, 355(9218):1875-1881.
15. Chan K., Puck J.M. Development of population-based newborn screening for severe combined immunodeficiency. J. Allergy Clin. Immunol. 2005, 115(2):391-398.
16. O'Marcaigh A.S., et al. Maternal mosaicism for a novel interleukin-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred. J. Clin. Immunol. 1997, 17(1):29-33.
17. Howell R.R. Report on Newborn Screening for Severe Combined Immunodeficiency 2011 2011, Secretary's Advisory Committee on Heritable Disorders in Newborns and Children, (Available from: http://www.hrsa.gov/advisorycommittees/mchbadvisory/heritabledisorders/recommendations/correspondence/severeimmunodeficiency.pdf. Last accessed August 12, 2014).
18. Hannon W.H., et al. Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline 2013, Clinical and Laboratory Standards Institute, Wayne, PA.
19. Kwong P.C., et al. Oral and genital ulceration: a unique presentation of immunodeficiency in Athabascan-speaking American Indian children with severe combined immunodeficiency. Arch. Dermatol. 1999, 135(8):927-931.
20. Tarini B.A., et al. Waiving informed consent in newborn screening research: balancing social value and respect. Am. J. Med. Genet. C: Semin. Med. Genet. 2008, 148C(1):23-30.
21. Botkin J.R., et al. Parental permission for pilot newborn screening research: guidelines from the NBSTRN. Pediatrics 2014, 133(2):e410-e417.
22. Feuchtbaum L., Cunningham G., Sciortino S. Questioning the need for informed consent: A case study of California's experience with a pilot newborn screening research project. J. Empir. Res. Hum. Res. Ethics 2007, 2(3):3-14.
23. Bakare N., et al. Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS). Vaccine 2010, 28(40):6609-6612.